Galectin Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $38k | 23k | 1.66 |
| 2023-09-30 | $44k | 23k | 1.92 |
| 2023-06-30 | $33k | 23k | 1.44 |
| 2023-03-31 | $49k | 23k | 2.10 |
| 2022-12-31 | $26k | 23k | 1.13 |
| 2022-09-30 | $38k | 23k | 1.65 |
| 2022-06-30 | $30k | 23k | 1.30 |
| 2022-03-31 | $37k | 23k | 1.60 |
| 2021-12-31 | $48k | 23k | 2.08 |
| 2021-09-30 | $90k | 23k | 3.90 |
| 2021-06-30 | $74k | 23k | 3.21 |
| 2021-03-31 | $212k | 100k | 2.12 |
| 2020-12-31 | $242k | 107k | 2.25 |
| 2020-09-30 | $294k | 111k | 2.66 |
| 2020-06-30 | $343k | 113k | 3.04 |
| 2020-03-31 | $222k | 114k | 1.94 |
| 2019-12-31 | $325k | 114k | 2.84 |
| 2019-09-30 | $414k | 113k | 3.67 |
| 2019-06-30 | $393k | 95k | 4.12 |
| 2019-03-31 | $99k | 19k | 5.12 |
| 2018-12-31 | $68k | 20k | 3.41 |
| 2018-09-30 | $120k | 20k | 6.02 |
| 2018-06-30 | $127k | 20k | 6.37 |
| 2018-03-31 | $123k | 26k | 4.76 |
| 2017-12-31 | $67k | 20k | 3.36 |
| 2017-06-30 | $51k | 21k | 2.46 |
| 2017-03-31 | $48k | 21k | 2.31 |
| 2016-12-31 | $22k | 22k | 1.00 |
| 2016-09-30 | $24k | 21k | 1.13 |
| 2016-06-30 | $36k | 25k | 1.46 |